Want to join the conversation?
For 2016, $STI is targeting revenue growth that exceeds expense growth, and thus, improved tangible efficiency ratio relative to 2015. $STI sees pace of improvement to be slower than prior years, as core expenses have already fell substantially, and operating environment, while improving in certain areas, remains challenging overall.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.